Cure Today27d
FDA Accepts New Drug Application For Taletrectinib in ROS1+ NSCLC
Confirmed Objective Response Rate (cORR): the percentage of patients ... of time a patient responds to treatment without their cancer growing or spreading. New Drug Application (NDA): a request to ...
Business Wire1mon
Epirium Bio Announces FDA Clearance of Investigational New Drug Application for MF-300 and Appointment of Alex Casdin as New Chief Executive Officer and Russell Cox as ...
The U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for ... The primary objective of the Phase 1 trial is to evaluate the safety ...